You are hereHome >
Comments To HHS On Blueprint To Lower Drug Prices
In response to a Request for Information from the Department of Health and Human Services (HHS) to comment on its "", we join Consumers Union and other leading groups in a comment letter. In particular, we detail ways to rein in abusive and anti-competitive practices of both Pharmacy Benefit Managers (PBMs) and Big Pharma's brand name drug companies that force American consumers to pay too much for health care. Our comments support many of the proposals from Secretary Azar and HHS.
Resource file downloadComments To HHS On Lowering Drug Prices
Your donation supports U.S. PIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.